Hankook Cosmetics 123690 Stock Outlook 2026: K-Beauty Re-Rating and the Economics of Selling Brands

Should You Buy a K-Beauty Story Through Hankook Cosmetics?

Here is my read. Hankook Cosmetics (KOSPI 123690) is not a K-beauty poster child. It is a test of whether a brand and distribution business can earn its keep in a market that changed shape. When the sector gets re-rated, attention arrives fast. Earnings arrive slowly, and only for companies that own brands people actually reach for.

First, a common mix-up. 123690 markets and sells cosmetics. Hankook Cosmetics Manufacturing (003350) makes them. Different business, different ticker, different risks. People buy the wrong one by matching names in a search box. If you want the manufacturing side, that is a separate stock. This piece is only about the marketing and sales company.

I have deliberately kept this qualitative. Quarterly figures and share prices go stale within weeks, while the structure of a brand business does not. Before you place an order, overwrite anything I say with the latest filing.

---

How Does a Cosmetics Marketing and Sales Company Make Money?

Picture the beauty industry in three layers. At the bottom sit ingredients and contract manufacturing. In the middle, brand development and marketing. On top, the sales channels. Hankook Cosmetics lives in the middle and the top.

The mechanics are simple. A brand owner outsources production, so it avoids the cost of a factory. What it pays for instead is memory: advertising, promotions, retailer fees and sales staff. When a product sells, gross margin is generous and what is left over is large. When it does not, inventory and marketing spend sit on the income statement as losses.

Feature	Brand and distribution company	Contract manufacturer (ODM)
Core asset	Brands, channel relationships	Plants, formulation expertise
Capital spending	Light	Heavy
Gross margin	Higher	Lower
Main costs	Advertising, retailer fees	Depreciation, labor
What moves earnings	Brand popularity, channel shifts	Customer orders, utilization
Signature risk	Gap in hit products	Customer concentration

Look at the risk row. The brand owner’s risk is popularity. The manufacturer’s risk is orders. Popularity can vanish in a season; orders usually survive until a contract ends. So brand companies make a lot in good years and lose a lot in bad ones. A high margin on paper is not a reason to relax.

One more mechanic. Companies that run their own sales channels keep the retailer’s cut, but they also take on the staff, the inventory and the risk when a channel declines. Door-to-door sales, department stores, drugstores, home shopping, online malls and overseas distributors all carry different margins and turn inventory at different speeds. Watching how the channel mix shifts tells you where margins are heading.

Korean small caps that sit between a customer and a shopper tend to follow this pattern. A good comparison is Youngone, which I covered in my Youngone Corp outlook. It builds products for global apparel brands, so it holds the manufacturing seat, not the brand seat. Read the two side by side and you see the same industry split into the two very different profit profiles above.

---

Will the K-Beauty Re-Rating Translate Into Earnings Here?

Let me separate the story from the substance. Korean cosmetics drew global attention for two reasons: strong quality for the price in skincare and color, and a quick cycle of new products pushed through social media and online channels. The companies whose earnings jumped most were either owners of recognized brands or specialists that gather K-beauty and sell it abroad.

For the halo to reach Hankook Cosmetics, at least two of three things need to be true.

One, there is a brand that actually sells overseas. Two, an export channel or partner is already in place. Three, new products can come out as quickly as those of indie rivals. If the company mostly runs older brands for the domestic market, the stock can rise with the sector but the move has no earnings behind it. Expectations without confirmation fade within a quarter or two.

My working rule for small-cap beauty in a re-rating phase: theme first, results later. The first stage is speculation, and the second is investing. You pay a little more for waiting until the numbers confirm, and that premium is worth paying.

---

Where Is the Moat in a Brand Portfolio?

A distributor’s moat is not a patent. It is relationships and habit, in three forms.

Brand recognition and repeat buyers. Skincare gets sticky. Once a shopper settles on a routine, she keeps buying. A brand that has lasted decades holds trust with a particular age group, and a startup cannot buy that with an ad budget in a year. The trap is that the base ages, and that trust erodes slowly.

Channel relationships. Shelf space, sales staff, promotional tie-ins and online ranking are all interlocked. A new brand does not get them quickly. If the channel itself declines, the asset shrinks with it.

Supply arrangements. A long relationship with a contract maker or affiliate helps speed and quality. What I check is whether related-party purchases are at market prices. The related-party section in the annual report tells you.

Counting brands is not a moat. A portfolio full of fading names is a liability. The first thing I look at is whether the biggest brand’s share of sales is rising or falling. If new brands are becoming the growth engine, that is encouraging. If old brands decline and new ones do not fill the gap, that is the warning.

Consumer-facing Korean businesses with an unusually strong brand can command a premium for years. The same question applies to Daesang, where I looked at how a branded food company defends shelf space in my Daesang outlook. A brand only counts as a moat if shoppers keep choosing it without a discount.

---

How Does It Compare With Big Groups, Contract Makers and Indie Brands?

Type	Examples	Strength	Weakness
Big integrated beauty groups	Amorepacific, LG H&H	Capital, distribution, ad scale	Ageing brands, China exposure
Contract manufacturers	Cosmax, Kolmar Korea	Formulation, scale economies	Customer concentration, thin margins
Indie and emerging brands	Clio and newer skincare and color labels	Online agility, overseas speed	Durability of popularity
Mid-sized brand distributors	Hankook Cosmetics	Long channel relationships	Must prove a growth engine

A mid-sized brand company sits in the fourth row. It cannot outspend the giants on advertising, and it has less of the agility that lets an indie brand ride a trend. So the sensible strategy is to focus on the one or two things it does well.

Indie brands are strong for a clear reason. Online commerce and cross-border platforms broke the old retail hold of the majors. Reviews and creators build awareness that used to require television. The big groups are large, which means they turn slowly. A mid-sized firm can survive in that gap only by shortening its product cycle and growing its online share.

The contract manufacturing layer matters here too. The explosion of indie labels was made possible by ODM infrastructure that lets anyone launch a brand. Lower barriers mean more competition and less scarcity for every single label. The relationship between a brand and its maker is comparable to the healthcare chain in the Boryung outlook, where who holds the product and who holds the customer decides who earns the margin.

---

What Are the Real Risks?

Hit dependence. One or two products carrying revenue is the standard failure mode. When they age, growth stops. If new launches do not replace them, earnings turn within a few quarters.

Channel shift. Shoppers move from stores to online, from domestic platforms to global ones. A company tied to traditional channels sees revenue erode, and the cost of running its own channels grows heavier.

Advertising burden. Spend more to protect revenue and profit shrinks. Spend less and revenue slips. The only way out is a base of repeat customers.

Small-cap liquidity. Thin trading means a single headline can move the price sharply. Buying is hard and selling is harder. Keep the position small.

China and duty-free exposure. Korean beauty has swung with Chinese consumption and duty-free channels for years. Check the geographic split of overseas sales in the annual report.

Related-party dealings. Confirm that terms with affiliates are at market level. A high internal-transaction share calls for more scrutiny of transparency.

---

How Should a Foreign Investor Think About Tax, FX and Access?

Since this is a Korean-listed stock, a US, UK or European holder faces Korean rules rather than home-market ones. Do not assume; confirm each item.

Item	What to check
Dividend withholding	Korea’s domestic rate versus the tax treaty rate for your country
Capital gains	Depends on treaty and holding size; many small investors are exempt, but confirm
Securities transaction tax	Charged on sales in Korea
Currency	KRW moves change your return in dollars, pounds or euros
Access	Broker must support KRX; some need foreign investor registration
Liquidity	Small-cap volume is thin; use limit orders

Two practical points. First, the currency can matter as much as the stock. A flat share price with a weaker won is a loss in your home currency, and the reverse is a hidden gain. Second, if your country taxes worldwide income, check whether Korean withholding can be credited against your own bill. For a general framework on how gains and reporting work elsewhere, my stock capital gains tax guide is a starting point, though you need treaty-specific advice for Korean holdings.

If income matters to you more than a turnaround story, a broad dividend fund may be easier to hold than a small consumer stock. I compare the approach in my SCHD dividend ETF guide.

---

What Do I Check Every Quarter?

• Sales by channel: are online and overseas rising, or is only the legacy channel holding steady?
• Gross margin: the thermometer for pricing power. A slide points to discount-driven sales.
• Advertising and selling expenses: if costs grow faster than revenue, that is buying growth, not earning it.
• Inventory and receivables: stock piling up while sales stall can mean new products are not landing.
• Related-party share: track the weight and terms of affiliate transactions.
• Largest-brand share of revenue: too high means hit dependence.

The one question I keep asking is whether growth comes from demand or from spending. Two quarters of revenue growth with falling margins is a warning, not a win.

---

Related Reading

• 👉 Youngone Corp 111770 Stock Outlook 2026
• 👉 Daesang 001680 Stock Outlook 2026
• 👉 Boryung 003850 Stock Outlook 2026
• 👉 Stock Capital Gains Tax Guide 2026
• 👉 SCHD Dividend ETF Guide 2026

---

This article is provided for informational purposes only and is not a recommendation to buy or sell any security. Investing involves risk, including loss of principal, and you should make decisions based on your own financial situation and risk tolerance. Company details and outlook reflect the time of writing, and tax rules vary by country and change over time. Check the latest filings and consult a qualified tax adviser before investing.